News

Filter

Current filters:

Ventavis

1 to 9 of 19 results

Soaring Tracleer sales boost Actelion’s 2009 financial results

19-02-2010

Switzerland-based Actelion, Europe’s largest biotechnology company, pleased investors yesterday…

BiotechnologybosentanDrug DiscoveryFinancialGlaxoSmithKlineGSKIloprostMiglustatPharmaceuticalTracleerVentavisZavesca

US FDA clears new formulation of Actelion’s Ventavis

10-08-2009

Actelion, a major European biotechnology firm based in Switzerland, says that the US Food and Drug Administration…

AspirinBayerBayerBiotechBiotechnologyCardio-vascularEuropeIloprostVentavis

2008 profit doubles for Actelion on 2007 costs

02-03-2009

Swiss drugmaker Actelion's profit for full-year 2008 more than doubled in comparison to its 2007 result,…

bosentanIloprostMiglustatTracleerVentavisZavesca

Actelion recovers from poor first quarter

04-08-2008

Swiss biotechnology firm Actelion reported improved results for the first six months of 2008 on the recovery…

bosentanIloprostMiglustatTracleerVentavisZavesca

Actelion's FY 2007 net revenues beat forecasts

28-01-2008

Swiss biotechnology firm Actelion's unaudited 2007 total net revenues reached 1.32 billion Swiss francs…

bosentanIloprostMiglustatNystatinOralTracleerVentavisZavesca

Actelion's 1st-qtr 2007 loss deepens 179%

30-04-2007

Swiss biotechnology firm Actelion says that its first-quarter 2007 net revenue rose to 290.4 million…

bosentanIloprostMiglustatNystatinOralTracleerVentavisZavesca

1 to 9 of 19 results

COMPANY SPOTLIGHT

Menarini

Back to top